At a glance
ClinicalIndex Comparison RecordN/ACompleted· 122 enrolled
Drug / intervention
ACCU-CHEKdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ACCU-CHEK Connect Personal Diabetes Management Study (PDM)
In Brief
A clinical study evaluating ACCU-CHEK for Diabetes Mellitus, Type 1. Completed, enrolled 122 participants across 11 sites.
Detailed Summary
This post-market, interventional, prospective, single arm, the United States (US) based multi-center study will assess the change in treatment satisfaction of participants who utilize the ACCU-CHEK Connect Diabetes Management System over a period of 6 months.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesUnited States
CollaboratorsRoche Diabetes Care
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedNov 2015
Enrollment StartDec 2015
Primary CompletionSep 2016
Study CompletionFeb 2017
TodayJul 2026
First PostedNov 9, 2015
Enrollment StartDec 30, 2015
Primary CompletionSep 29, 2016
Study CompletionFeb 20, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.6 years ago
Interventions
ACCU-CHEKdevice
ACCU-CHEK Connect Diabetes Management System contains ACCU-CHEK Aviva Connect Blood Glucose Monitoring System, ACCU-CHEK Connect Diabetes Management App, and ACCU-CHEK Connect Online Diabetes Management System.